Related references
Note: Only part of the references are listed.Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection
T. -C. Tseng et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: A need for surveillance
Gi-Ae Kim et al.
JOURNAL OF HEPATOLOGY (2015)
Serological and clinical outcomes of horizontally transmitted chronic hepatitis B infection in New Zealand Maori: results from a 28-year follow-up study
Tien Huey Lim et al.
GUT (2015)
Risk of hepatocellular carcinoma in cirrhotic hepatitis B virus patients during nucleoside/nucleotide analog therapy
Etsuro Orito et al.
HEPATOLOGY RESEARCH (2015)
Long-term outcome in Caucasian patients with chronic hepatitis B virus infection after HBsAg seroclearance
Eugenia Lauret et al.
LIVER INTERNATIONAL (2015)
HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability
Gi-Ae Kim et al.
GUT (2014)
Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma
Jessica Liu et al.
GUT (2014)
Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease
Ju-Yeon Cho et al.
GUT (2014)
Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load
Tai-Chung Tseng et al.
HEPATOLOGY (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients
R. Idilman et al.
JOURNAL OF VIRAL HEPATITIS (2012)
HBsAg Seroclearance in Chronic Hepatitis B Implications for Hepatocellular Carcinoma
Ji Hoon Kim et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)
Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss
Roeland Zoutendijk et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Hepatitis B surface antigen seroclearance during chronic HBV infection
Chia-Ming Chu et al.
ANTIVIRAL THERAPY (2010)
Clearance of Hepatitis B Surface Antigen and Risk of Hepatocellular Carcinoma in a Cohort Chronically Infected with Hepatitis B Virus
Josephine Simonetti et al.
HEPATOLOGY (2010)
Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies
A. J. Mitchell et al.
ACTA PSYCHIATRICA SCANDINAVICA (2009)
Development of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen
Myron John Tong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
Alessandro Liberati et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study
Rami Moucari et al.
JOURNAL OF HEPATOLOGY (2009)
Hepatitis B Virus Infection and Hepatocellular Carcinoma Among Parous Taiwanese Women: Nationwide Cohort Study
Chyng-Wen Fwu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
HBsAg seroclearance in chronic hepatitis B in Asian patients: Replicative level and risk of hepatocellular carcinoma
Man-Fung Yuen et al.
GASTROENTEROLOGY (2008)
Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response
Henry Lik-Yuen Chan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Epidemiology and natural history of hepatitis B
BJ McMahon
SEMINARS IN LIVER DISEASE (2005)
Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance
SH Ahn et al.
JOURNAL OF HEPATOLOGY (2005)
Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen
Y Murakami et al.
JOURNAL OF MEDICAL VIROLOGY (2004)
HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspects
MF Yuen et al.
HEPATOLOGY (2004)
Identification of a novel pre-S2 mutation in a subgroup of chronic carriers with spontaneous clearance of hepatitis B virus surface antigen
CT Yeh et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection
YC Chen et al.
GASTROENTEROLOGY (2002)
Serologic and clinical outcomes of 1536 Alaska natives chronically infected with hepatitis B virus
BJ McMahon et al.
ANNALS OF INTERNAL MEDICINE (2001)
The power of statistical tests in meta-analysis
LV Hedges et al.
PSYCHOLOGICAL METHODS (2001)
On judging the significance of differences by examining the overlap between confidence intervals
N Schenker et al.
AMERICAN STATISTICIAN (2001)
Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen:: Clinically significant or purely occult?
C Bréchot et al.
HEPATOLOGY (2001)
Share Paper
